Table 1.
Characteristics | Patients | CENPU expression | p value | |
---|---|---|---|---|
N=80 | High | Low | ||
Age | 0.4912 | |||
< 65 | 49 | 23 | 26 | |
≥ 65 | 31 | 17 | 14 | |
Gender | 0.5923 | |||
Female | 18 | 10 | 8 | |
Male | 62 | 30 | 32 | |
Tumour Size (cm) | 0.1521 | |||
< 5 | 54 | 24 | 30 | |
≥ 5 | 26 | 16 | 10 | |
AFP (μg/L) | 0.1709 | |||
< 400 | 48 | 21 | 27 | |
≥ 400 | 32 | 19 | 13 | |
PVTT | 0.0253* | |||
No | 64 | 28 | 36 | |
Yes | 16 | 12 | 4 | |
TNM stage | 0.0147* | |||
I+II | 56 | 23 | 33 | |
III+IV | 24 | 17 | 7 | |
Cirrhosis | 0.4693 | |||
No | 25 | 11 | 14 | |
Yes | 55 | 29 | 26 | |
HBV infection | 0.1035 | |||
No | 29 | 11 | 18 | |
Yes | 51 | 29 | 22 | |
Lymph metastasis | 0.7094 | |||
No | 72 | 37 | 35 | |
Yes | 8 | 3 | 5 | |
BCLC stage | 0.0452* | |||
Low | 58 | 25 | 33 | |
High | 22 | 15 | 7 |
PVTT: portal vein tumour thrombus; BCLC: Barcelona Clinic Liver Cancer.
Bold italics indicate statistically significant values (*p < 0.05).